期刊文献+

雷洛昔芬与大豆异黄酮对绝经后妇女骨代谢影响的比较 被引量:4

下载PDF
导出
摘要 目的比较雷洛昔芬与大豆异黄酮对绝经后妇女骨代谢指标及骨密度的影响。方法 75例健康绝经后妇女随机均分为3组。雷洛昔芬组每日口服雷洛昔芬60 mg,大豆异黄酮组每日口服大豆异黄酮90 mg,安慰剂组口服安慰剂。并于服药前及服药12个月后各进行1次骨密度、骨代谢生化指标的测定。结果用药后雷洛昔芬组桡骨骨密度升高,血清钙、碱性磷酸酶、骨钙素(BGP)、尿钙/尿肌酐比值水平下降(P<0.05);大豆异黄酮组仅碱性磷酸酶、BGP水平下降(P<0.05)。雷洛昔芬组和大豆异黄酮组各指标均无显著性差异(P>0.05)。结论雷洛昔芬较大豆异黄酮对防治绝经后妇女骨质疏松疗效可能更明显一些。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2011年第7期1124-1126,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献7

  • 1Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative Randomized Controlled Trial [J]. JAMA, 2004 ; 291 (14) :1701-12.
  • 2Tempfer CB, Froese G, Heinze G,et al. Side effects of phytoestrogens : a meta-analysis of randomized trials [J]. Am J Med,2009 ; 122 (10) :939-46.
  • 3高会玲.绝经后骨质疏松的药物治疗进展[J].中国妇幼保健,2008,23(7):1010-1012. 被引量:5
  • 4Gupta G, Aronow WS. Treatment of postmenopausal osteoporosis [J]. Compr Ther,2007 ;33 ( 3 ) : 114-9.
  • 5高艳萍,李润红,郭述真.大豆异黄酮对绝经后妇女骨代谢的影响[J].山西医科大学学报,2006,37(6):633-635. 被引量:4
  • 6郑淑蓉,吴宜勇,张忠兰,杨欣,惠英,张颖,陈淑玲,邓文慧,刘慧,Abie Ekangaki,Jodie Stocks,Kristine Harper,刘建立.雷洛昔芬对绝经后妇女骨密度、骨代谢生化指标和血脂影响的随机对照研究[J].中华妇产科杂志,2003,38(4):226-229. 被引量:10
  • 7Johnston CC, Bjarnasona NH, Cohen FJ, et al. Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women:three-year data from 2 double-blind, ran- domized, placebo-controlled trials [J]. Arch Intern Med, 2000 ; 160 ( 22 ) :3444-50.

二级参考文献22

  • 1鞠月迎.绝经后骨质疏松症的药物预防与治疗指南[J].世界临床药物,2006,27(5):262-265. 被引量:9
  • 2Minisola S,Pacitti MT,Ombricolo E,et al.Bone turnover and its relationship with bone mineral density in pre-and postmenopausal women with or without fractures[J].Maturitas,1998,29:265-270.
  • 3Reinlik,Block G.Phytoestrogen content of foods compendium of literacure values[J].Nutr Cancer,1996,26:123-128.
  • 4Arjmandi BH,Alekel L,Hollis BW,et al.Dietary soybean protein prevent bone loss in an ovariectomized rat model of osteoprosis[J].J Nutr,1996,126:161-167.
  • 5Uesugi T,Toda T,Tsuji K,et al.Comparative study on reduction of bone loss and lipid metabolism abnormality in ovariectomized rats by soy flavones daidzin genistin and glytin[J].Biol Pharm Bull,2001,24:368-372.
  • 6Potter SM,Baum JA,Teng H,et al.Soy protein and isoflavones:their effects on blood lipids and bone density in postmenopausal women[J].Am J Clin Nutr,1998,68:1375-1379.
  • 7Alekel DL,Germain AS,Peterson CT,et al.Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women[J].Am J Clin Nutr,2000,72:844 -852.
  • 8Bloeden LT,Jeffcoat AR,Lopaczynski W,et al.Safety and pharmacokinetics of purified soy isoflavones:single dose administration to postmenopausal women[J].Am J Clin Nutr,2002,76:1126-1137.
  • 9李春光.甲状旁腺激素(1-34)对绝经后骨质疏松妇女骨折和骨矿物质密度的影响.国外医学:药学分册,2002,29(3):182-183.
  • 10Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal resuits From the Women's Health Initiative randomized controlled trial. JAMA, 2002,288(3):321

共引文献16

同被引文献39

引证文献4

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部